Shanghai Chest Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Shanghai Chest Hospital
RECRUITINGPhase 2NCT06127303
Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
Immunotherapy with programmed death-1(PD-1) inhibitors is now standard therapy for first-line use in patients with driver-negative advanced NSCLC, whether as single-agent or in...
Sponsor: Shanghai Chest HospitalEnrolling: 543 locations
Non-small Cell Lung Cancer
RECRUITINGNCT07122336
Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation
The design of this study is an intervention, randomized, controlled study and contains three randomized groups:(1)PVI group;(2)PVI+PWI group;(3)PVI+PWI+EGM group.
Sponsor: Shanghai Chest HospitalEnrolling: 3841 location
Persistent Atrial Fibrillation
RECRUITINGNCT07045532
Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI
A Clinical Study Based on Magnetic Resonance Imaging of the Lungs to Assess the Efficacy of Thermal Vapor Ablation and Pulmonary Nodule Ablation in Chronic Obstructive Pulmonary...
Sponsor: Shanghai Chest HospitalEnrolling: 1001 location
COPDLung Cancers